Ronald Joe
Overview
Explore the profile of Ronald Joe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yazdani K, Dolguikh K, Ye M, Trigg J, Joe R, Emerson S, et al.
Prev Med Rep
. 2023 Jul;
35:102305.
PMID: 37519440
Accidental overdoses are now the leading cause of death among people with HIV (PWH) in British Columbia (BC). We examined the utilization and retention of opioid agonist therapy (OAT). Adult...
2.
Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, et al.
J Subst Use Addict Treat
. 2023 Mar;
148:209005.
PMID: 36921770
Introduction: Limited research examines buprenorphine-naloxone interest among adolescents and young adults (AYA). This longitudinal study examined factors associated with initial buprenorphine-naloxone interest and the time to a positive change in...
3.
Pilarinos A, Kwa Y, Joe R, Dong H, Grant C, Fast D, et al.
Can J Psychiatry
. 2022 Nov;
68(2):89-100.
PMID: 36377240
Objective: Retaining adolescents and young adults (AYA) in medications for opioid use disorder (MOUD), like methadone maintenance treatment (MMT), is critical to reducing toxic drug fatalities. This analysis sought to...
4.
Hajek J, Chamberlaine M, Baldwin N, Joe R
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
4(3):190-192.
PMID: 36340647
The opioid crisis and complications related to injection drug use are a public health emergency. The combination of addiction and injection drug use is a devastating double-edged sword: it predisposes...
5.
Pilarinos A, Kwa Y, Joe R, Thulien M, Buxton J, DeBeck K, et al.
Int J Drug Policy
. 2022 Jul;
107:103773.
PMID: 35780565
Background: Opioid agonist therapy (OAT) has been shown to reduce opioid use and related harms. However, many young people are not accessing OAT. This study sought to explore how young...
6.
Pilarinos A, Fast D, Nosova E, Kwa Y, Joe R, Buxton J, et al.
Drug Alcohol Depend
. 2022 Apr;
235:109441.
PMID: 35427979
Background: Opioid agonist treatments (OAT) are effective interventions for reducing illicit opioid use; however, less is known about OAT among adolescents and young adults (AYA). This study sought to examine...
7.
Joe R, Sincraian G, Shukor A
Perm J
. 2021 Feb;
25:1.
PMID: 33635763
Background: Community health centers (CHCs) in British Columbia, Canada, are using a data-driven approach to enable functions related to the design, organization, management, delivery, and evaluation of primary health care...
8.
Homayra F, Pearce L, Wang L, Panagiotoglou D, Sambo T, Smith N, et al.
Int J Epidemiol
. 2020 Oct;
49(6):1776.
PMID: 33097934
No abstract available.
9.
Hayashi K, Ti L, Dong H, Bingham B, Day A, Joe R, et al.
PLoS One
. 2019 Nov;
14(11):e0224993.
PMID: 31725737
Background: Urban drug scenes are characterized by high prevalence of illicit drug dealing and use, violence and poverty, much of which is driven by the criminalization of people who use...
10.
Shukor A, Joe R, Sincraian G, Klazinga N, Kringos D
Community Ment Health J
. 2019 Jun;
55(8):1326-1343.
PMID: 31177480
Operationalization of the fundamental building blocks of primary care (i.e. empanelment, team-based care and population management) within the context of Community Health Centers requires accurate and real-time measures of biopsychosocial...